The options market spent the week before Lam Research’s earnings bracing for turbulence. Shares were under pressure as traders braced for a sharp post-earnings swing, with call activity outpacing puts but elevated implied volatility signaling uncertainty rather than confidence. What arrived Wednesday night was something different: not turbulence, but a structural reset of the entire wafer fabrication equipment investment thesis.
The Signal
When a company guides $1 billion above Wall Street’s consensus, options pricing does not recover gracefully, it moves violently. For fiscal Q1 2027, Lam forecast adjusted earnings of $2.15 per share on revenue of $8.1 billion; analysts had expected $1.84 per share on sales of $7.11 billion. That $1 billion revenue gap is not a rounding error. It tells you either that institutional estimates for the AI semiconductor equipment cycle were materially wrong, or that Lam has achieved a demand position its competitors cannot yet replicate.
The immediate options reaction confirmed the shock. Lam Research shares soared on Thursday after the semiconductor equipment maker delivered better-than-expected fiscal fourth-quarter results and issued stronger guidance, with the stock climbing about 23% in the session. With a beta of 1.92 and a stock that was down 7% into the close on earnings day before reversing sharply after hours, the volatility surface on LRCX was fully exposed. Anyone holding short-dated puts into the earnings release was crushed. Anyone who had positioned for a modest post-earnings drift undershot by roughly four standard deviations.
Why It Matters
This is not a story about a single quarter. The guidance number landed at $8.1 billion, but the more important signal is what management said about the shape of demand. Management lifted its 2026 wafer fabrication equipment estimate to the low-$150 billion range from $140 billion, with CEO Tim Archer saying: “Looking into 2027, we see an extraordinary outlook for WFE growth.” That comment is the kind of forward visibility that does not appear in one earnings call. It reflects what customers are actually ordering and committing to, not what analysts have modeled.
The read-through spread immediately. Applied Materials, KLA, and ASML all rallied, while the iShares Semiconductor ETF gained 8.0%. When the equipment ecosystem moves in unison on one company’s guidance, the market is moving a cycle, not a quarter.
The Company Behind the Signal
Lam Research reported fourth-quarter revenue of $6.72 billion, beating analyst estimates of $6.67 billion. The company posted adjusted earnings of $1.82 per share, beating estimates of $1.68. Gross margin came in at 51.7% and operating margin was 37.4% in the quarter. Both were records. The support business, which provides upgrades and services on the installed base, posted its third consecutive quarterly record.
The company is benefiting from rising investments in advanced DRAM, HBM, and leading-edge foundry technologies, all of which require Lam’s etch and deposition equipment. Management also expects advanced packaging revenues to grow more than 50% in calendar year 2026 as AI processors become more complex and require sophisticated chip integration technologies.
China remains an open variable. China generated 26% of June-quarter revenue, while domestic Chinese customers declined sequentially. Export controls and stretched lead times can disrupt shipments. That geographic concentration is the clearest tail risk on the thesis.
Market Expectations
The stock’s 52-week range tells the real story. The 52-week range spans from $90.94 to $438.50. The stock closed at roughly $252 before the earnings release and surged above $295 after hours. Even after that move, it remains more than 30% below its cycle peak.
The forward valuation is recalibrating in real time. LRCX is priced at approximately $303, corresponding to 33.7 times FactSet’s projected fiscal 2027 EPS of $8.99, which has risen from $8.08 over the past month. That multiple, applied to a business guiding 20%+ sequential revenue growth into September, is not obviously expensive if the WFE cycle holds. The question the options market must now answer is whether the guidance represents a durable inflection or a peak-cycle pull-forward.
Twenty-one out of 24 analysts tracked rated the stock a buy, with three holds and no sells. The consensus price target stood at $381.89, roughly 26% above the post-earnings price of around $303. That gap between analyst targets and current price, in the wake of a massive guidance beat, is exactly the kind of mispricing the options market starts to price out rapidly.
Strategic Considerations
The options signal here is about what happens to implied volatility now that the event has passed. Before earnings, IV was elevated and directionally confused, calls outnumbered puts but IV implied more fear than conviction. After an 18%-to-23% single-session surge, near-term IV collapses. That creates a specific opportunity: selling the remaining volatility premium that has not yet fully deflated, or using it to structure a defined-risk position that captures continued momentum at a lower cost basis than buying stock outright.
A bull call spread in the September or October expiration, buying the roughly at-the-money call and selling a strike 10%-to-15% out of the money, captures the run toward analyst targets while defining maximum loss. This is not a cheap trade on an absolute basis, the stock has already moved, but the spread structure reduces the cost of entry relative to a straight long call. The key mechanics: time decay works against the long leg, so the trade needs either continued upward momentum or a period of stable-to-rising stock price to perform. If IV continues compressing, the spread loses its edge faster.
A more conservative approach for investors who want exposure to the WFE cycle without single-stock risk is a diagonal spread: buy a longer-dated call (January 2027) at a reasonable strike and sell a shorter-dated call against it monthly. This reduces the cost basis over time and gives the thesis room to develop without requiring an immediate price catalyst. The risk is that the stock reverses sharply, making the long leg worthless regardless of the short call premium collected.
What no one should be doing is ignoring the signal. A $1 billion guidance beat in a $140 billion-to-$150 billion industry, from the company with the largest etch and deposition share, does not happen in a soft cycle.
What to Watch
Three things deserve close monitoring over the next 30 to 60 days. First, Applied Materials reports next. The whole equipment complex rallied on Lam’s stronger AI and memory read-through, and Lam’s strength is a leading indicator for broader process tool demand across leading-edge foundry, advanced packaging, and DRAM and NAND upgrades. If AMAT’s results diverge from Lam’s optimism, the thesis weakens.
Second, watch China export control headlines. Any tightening of restrictions on semiconductor equipment sales narrows the addressable market for Lam’s installed base, instantly. The 26% China revenue concentration is not a hidden risk; it is the primary downside scenario.
Third, the July 14, 2026 mid-year forecast from SEMI projects wafer fab equipment sales will reach the $200 billion mark in 2028. If that trajectory holds, the September quarter guidance of $8.1 billion is not the ceiling. It is a waypoint. How the stock holds the post-earnings gap over the next two weeks will reveal whether buyers are treating this as a structural entry or a tactical short-covering bounce.